Primary systemic therapy in operable breast cancer
AC Wolff, NE Davidson - Journal of clinical oncology, 2000 - ascopubs.org
PURPOSE: Laboratory studies suggest that primary systemic therapy (PST) could improve
control of micrometastatic disease and impact on overall survival (OS). This article examines …
control of micrometastatic disease and impact on overall survival (OS). This article examines …
Primary systemic therapy in operable breast cancer
AC Wolff, NE Davidson - Journal of Clinical Oncology, 2000 - pure.johnshopkins.edu
Purpose: Laboratory studies suggest that primary systemic therapy (PST) could improve
control of micro-metastatic disease and impact on overall survival (OS). This article …
control of micro-metastatic disease and impact on overall survival (OS). This article …
[引用][C] Primary systemic therapy in operable breast cancer
AC WOLFF, NE DAVIDSON - Journal of clinical oncology, 2000 - pascal-francis.inist.fr
Primary systemic therapy in operable breast cancer CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Primary systemic therapy in operable breast cancer
AC Wolff, NE Davidson - Journal of Clinical Oncology, 2000 - jhu.pure.elsevier.com
Purpose: Laboratory studies suggest that primary systemic therapy (PST) could improve
control of micro-metastatic disease and impact on overall survival (OS). This article …
control of micro-metastatic disease and impact on overall survival (OS). This article …
Primary systemic therapy in operable breast cancer
AC Wolff, NE Davidson - Journal of clinical oncology …, 2000 - pubmed.ncbi.nlm.nih.gov
Purpose Laboratory studies suggest that primary systemic therapy (PST) could improve
control of micrometastatic disease and impact on overall survival (OS). This article examines …
control of micrometastatic disease and impact on overall survival (OS). This article examines …
[引用][C] Primary systemic therapy in operable breast cancer
AC WOLFF - J Clin Oncol, 2000 - cir.nii.ac.jp
Primary systemic therapy in operable breast cancer.
AC Wolff, NE Davidson - … of Clinical Oncology: Official Journal of the …, 2000 - europepmc.org
Purpose Laboratory studies suggest that primary systemic therapy (PST) could improve
control of micrometastatic disease and impact on overall survival (OS). This article examines …
control of micrometastatic disease and impact on overall survival (OS). This article examines …
Primary systemic therapy in operable breast cancer
AC Wolff, NE Davidson - Database of Abstracts of Reviews of …, 2000 - ncbi.nlm.nih.gov
Does the use of primary chemotherapy result in the loss of standard prognostic factors (eg
tumour size, nodal involvement and hormone receptor status) that are normally used to …
tumour size, nodal involvement and hormone receptor status) that are normally used to …